Verity & Verity, LLC Eli Lilly & CO Transaction History

Verity & Verity, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$592.2 - $792.28 $150 Million - $200 Million	252,940 New	252,940 $197 Million
Q1 2023 Nov 07, 2024	BUY	$310.63 - $364.82 $651,391 - $765,027	2,097 New	2,097 $720,000
Q1 2023 May 02, 2024	SELL	$310.63 - $364.82 $77.9 Million - $91.5 Million	-250,843 Reduced 99.17%	2,097 $720,000
Q1 2023 Apr 03, 2023	SELL	$310.63 - $364.82 $449,792 - $528,259	-1,448 Reduced 40.85%	2,097 $720,000
Q4 2022 Jan 11, 2023	BUY	$321.55 - $374.67 $1.14 Million - $1.33 Million	3,545 New	3,545 $0

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Verity & Verity, LLC, based on Form 13F filings with the SEC.

Stay updated on Verity & Verity, LLC with notifications on news.